- Price as of: Jun 28, 08:10 PM EDT
AMGN Stock Dividend DataAdd AMGN to Watchlist
Looking to buy or sell AMGN?
AMGN Upcoming Dividend Payouts
AMGN Dividend Yield & Stock Price History
AMGN Dividend Payout History
AMGN Daily Snapshot
- Quote Time:
- Jun 28, 08:10 PM
- Today's Volume:
- Open Price:
- Day's Range:
- $145.60 - $148.42
- Previous Close:
- 52 Week Low / High:
- $130.09 - $181.81
- Percent Off 52 Week High:
AMGN Dividend Growth History
Last 5 Yrs
Last 3 Yrs
AMGN Dividend History
|Payout Amount||Declared Date||Ex-Dividend Date||Record Date||Pay Date ▼||Qualified Dividend?||Payout Type||Frequency|
AMGN Company Profile
Amgen (AMGN) - this company discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body's response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
January 27, 2015
After the bell on Tuesday, a number of big name, dividend paying companies announced their quarterly earnings. Below, we look at these earnings reports and break down the important points for investors.
February 09, 2015
Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its upcoming dividend payout. For more information, check out Everything Investors Need to Know About...
August 12, 2015
Dividends are an effective income generation tool for both short- and long-term investors. To capitalize on dividends, investors must ensure that they purchase the stock before the ex-dividend date and hold the stock through this period. Payments...
January 25, 2016
After last week’s continued bout of volatility, investors are going to experience smooth sailing this week. (I can’t even type that with a straight face.) This week really promises to be another rollercoaster of news- and data-driven surges and...
January 29, 2016
At this point, investor’s should be used to the up and down swings of the market. The last trading week of the month proved to be another roller coaster ride for stocks as investors digested a ton of data, policy announcements and earnings...
May 04, 2016
There are 15 major stocks going ex-dividend next week. If you buy the stock one day prior to the ex-dividend date, your name goes on the company’s record books and you receive the dividend on the record date. A stock with the least correction off...
June 22, 2016
When investors think of biotech stocks, the word “lottery” comes to mind. And for the most part, they are right. The vast bulk of the sector made up of smaller, early-stage drug developers with only one, or maybe two, new therapies in development....
Analyst Moves: General Electric Company, Oracle Corporation, Hewlett-Packard Company, More (GE, ORCL, HPQ, More)Jan 6, 2015Before Tuesday’s opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst...
Jan 5, 2015Before Monday's opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst...
Nov 7, 2014Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its...